Detailed Preliminary BETonMACE Results Conference Call & Webcast

A conference call and webcast will be held to supplement the presentation of BETonMACE results to be made during the American Heart Association’s (“AHA”) annual conference. As previously reported, the primary results of the BETonMACE trial will be presented on November 16th during the AHA’s Scientific Sessions 2019 held in Philadelphia, Pennsylvania; additional details can be found HERE. Following the AHA presentation, the Company will host a conference call and webcast currently scheduled for 8:30 am ET on November 18th, 2019.

For those wishing to join the November 18th event, it is highly recommended to access the webcast over the Internet using the following LINK. A replay of the webcast (using the same link provided) will be available for one month following the conclusion of the event.

The presentation slides can also be downloaded HERE.

If dialing in by phone, dial 1-800-319-4610 (within Canada / USA) or +1-604-638-5340 (International Toll). Callers should dial-in at least 10 min prior to the scheduled start time. A teleconference replay will be available for one month following the conclusion of the event and can be accessed by dialing 1-800-319-6413 (within Canada / USA) or +1-604-638-9010 (International Toll) and using the replay access code: 3856#.